HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Regional lymphadenectomy for renal pelvic and ureteral cancers].

Abstract
Thirty-four patients with renal pelvic and ureteral cancers received regional lymphadenectomy since 1980. The patients consisted of 21 with renal pelvic cancers, 10 with ureteral and 3 with renal pelvic and ipsilateral ureteral. Fifteen patients (44.1%) had metastatic nodes: 13 with renal hilar or para-aortic metastases and 2 with pelvic nodal involvements only. Thirteen of these 15 patients with nodal metastasis had high grade tumors and 14 had high stage tumors. The 5-year survival rate of these 15 patients was 26.3% which was considerably poor when compared with 19 patients without metastasis. Twenty patients with high grade and high stage tumors who received respective operations with regional lymphadenectomy had significantly better prognosis compared with the historical control group (15 patients, from 1961 to 1979). Additional regional lymphadenectomy for renal pelvic and ureteral cancers appears to be a valuable operation for improving prognosis.
AuthorsT Okano, S Isaka, K Abe, T Igarashi, S Murakami, O Matsuzaki, J Shimazaki
JournalNihon Hinyokika Gakkai zasshi. The japanese journal of urology (Nihon Hinyokika Gakkai Zasshi) Vol. 82 Issue 5 Pg. 816-20 (May 1991) ISSN: 0021-5287 [Print] Japan
PMID1875576 (Publication Type: English Abstract, Journal Article)
Topics
  • Adult
  • Aged
  • Carcinoma, Squamous Cell (mortality, pathology, surgery)
  • Carcinoma, Transitional Cell (mortality, pathology, surgery)
  • Female
  • Humans
  • Kidney Neoplasms (mortality, pathology, surgery)
  • Kidney Pelvis
  • Lymph Node Excision
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Prognosis
  • Survival Rate
  • Ureteral Neoplasms (mortality, pathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: